Please enable JavaScript to continue using this application.

Compare $CGEM vs $MGTX | Chartloom

Compare

$CGEM vs $MGTX

Cullinan Therapeutics Inc · MeiraGTx Holdings PLC

CGEM

Cullinan Therapeutics Inc

MGTX

MeiraGTx Holdings PLC

Compare $CGEM vs $MGTX

Comparing Cullinan Therapeutics Inc and MeiraGTx Holdings PLC

CGEMCullinan Therapeutics Inc

MGTXMeiraGTx Holdings PLC

CGEMCullinan Therapeutics Inc

Market cap

$954M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

53.5%

52W performance

140.8%

FCF yield

-16.7%

MGTXMeiraGTx Holdings PLC

Market cap

$990M

P/E (TTM)

12.70x

Forward P/E (NTM)

—

Forward P/S (NTM)

27.71x

Rev growth (TTM)

948.3%

YTD performance

36.9%

52W performance

29.4%

FCF yield

1.1%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

CGEM

MGTX

Detailed metrics comparison

CGEM

Cullinan Therapeutics Inc

MGTX

MeiraGTx Holdings PLC

Market Cap

CGEM$954M

MGTX$990M

Enterprise Value

CGEM$876M

MGTX$947M

Price

CGEM$15.53

MGTX$10.69

P/E Ratio

CGEMN/A

MGTX12.70x

P/S Ratio

CGEM0.00x

MGTX2.49x

EV/Sales

CGEM0.00x

MGTX2.38x

EV/EBITDA

CGEM8.02x

MGTX4.63x

P/B Ratio

CGEM3.10x

MGTX4.81x

P/FCF Ratio

CGEMN/A

MGTX94.58x

EV/FCF

CGEM-5.50x

MGTX90.47x

PEG Ratio

CGEMN/A

MGTXN/A

Forward P/E (NTM)

CGEMN/A

MGTXN/A

Forward P/S (NTM)

CGEMN/A

MGTX27.71x

Revenue (TTM)

CGEM$0

MGTX$398M

Revenue Growth (YoY)

CGEMN/A

MGTX948.3%

Forward Rev Growth

CGEM244.6%

MGTX-75.7%

Gross Margin (TTM)

CGEM0.0%

MGTX97.9%

Operating Margin (TTM)

CGEM0.0%

MGTX46.3%

EBITDA Margin (TTM)

CGEM0.0%

MGTX49.3%

Net Margin (TTM)

CGEM0.0%

MGTX19.9%

FCF Margin (TTM)

CGEMN/A

MGTX2.6%

Net Income (TTM)

CGEM$-205M

MGTX$79M

FCF (TTM)

CGEM$-159M

MGTX$10M

EPS (TTM)

CGEM-$3.33

MGTX$0.84

ROE (TTM)

CGEM-5289.0%

MGTX74.6%

ROA (TTM)

CGEM-4818.0%

MGTX29.4%

ROIC (TTM)

CGEM-5289.0%

MGTX50.9%

Cash

CGEM$79M

MGTX$143M

Debt

CGEM$0

MGTX$100M

Net Cash/Debt

CGEM$79M

MGTX$43M

Current Ratio (TTM)

CGEM8.42x

MGTX3.76x

Quick Ratio (TTM)

CGEM8.23x

MGTX3.69x

Debt/Equity (TTM)

CGEM0.00x

MGTX0.46x

Debt/Assets (TTM)

CGEM0.0%

MGTX0.0%

Interest Coverage (TTM)

CGEMN/A

MGTXN/A

Net Debt/EBITDA (TTM)

CGEM0.00x

MGTX0.00x

Beta

CGEM-0.03

MGTX1.05

52W Performance

CGEM140.8%

MGTX29.4%

YTD Performance

CGEM53.5%

MGTX36.9%

% from 52W High

CGEM-33.0%

MGTX-30.4%

% from 52W Low

CGEM138.9%

MGTX61.5%

Asset Turnover (TTM)

CGEM0.00x

MGTX1.48x

FCF Yield (TTM)

CGEM-16.7%

MGTX1.1%

Earnings Yield (TTM)

CGEM-21.4%

MGTX8.0%

Dividend Yield (TTM)

CGEMN/A

MGTXN/A

Rule of 40

CGEM0.0

MGTX951.0

EV/GP/RG

CGEMN/A

MGTXN/A

Ticker research

View CGEM research View MGTX research

Metric	CGEM Cullinan Therapeutics Inc	MGTX MeiraGTx Holdings PLC
Market & Valuation
Market Cap	$954M	$990M
Enterprise Value	$876M	$947M
Price	$15.53	$10.69
P/E Ratio	N/A	12.70x
P/S Ratio	0.00x	2.49x
EV/Sales	0.00x	2.38x
EV/EBITDA	8.02x	4.63x
P/B Ratio	3.10x	4.81x
P/FCF Ratio	N/A	94.58x
EV/FCF	-5.50x	90.47x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	27.71x
Revenue & Growth
Revenue (TTM)	$0	$398M
Revenue Growth (YoY)	N/A	948.3%
Forward Rev Growth	244.6%	-75.7%
Profitability
Gross Margin (TTM)	0.0%	97.9%
Operating Margin (TTM)	0.0%	46.3%
EBITDA Margin (TTM)	0.0%	49.3%
Net Margin (TTM)	0.0%	19.9%
FCF Margin (TTM)	N/A	2.6%
Net Income (TTM)	$-205M	$79M
FCF (TTM)	$-159M	$10M
EPS (TTM)	-$3.33	$0.84
ROE (TTM)	-5289.0%	74.6%
ROA (TTM)	-4818.0%	29.4%
ROIC (TTM)	-5289.0%	50.9%
Financial Health
Cash	$79M	$143M
Debt	$0	$100M
Net Cash/Debt	$79M	$43M
Current Ratio (TTM)	8.42x	3.76x
Quick Ratio (TTM)	8.23x	3.69x
Debt/Equity (TTM)	0.00x	0.46x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	-0.03	1.05
52W Performance	140.8%	29.4%
YTD Performance	53.5%	36.9%
% from 52W High	-33.0%	-30.4%
% from 52W Low	138.9%	61.5%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	1.48x
FCF Yield (TTM)	-16.7%	1.1%
Earnings Yield (TTM)	-21.4%	8.0%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	951.0
EV/GP/RG	N/A	N/A
Ticker research	View CGEM research	View MGTX research

Valuation

P/E Ratio

MGTX

12.70x

P/S Ratio

CGEM

0.00x

MGTX

2.49x

EV/FCF

CGEM

-5.50x

MGTX

90.47x

Growth & revenue

Revenue Growth TTM

MGTX

948.3%

Forward Revenue Growth

CGEM

244.6%

MGTX

-75.7%

Profitability & performance

Gross Margin

MGTX

97.9%

CGEM

0.0%

ROE

MGTX

74.6%

CGEM

-5289.0%

FCF Yield %

MGTX

1.1%

CGEM

-16.7%

52-Week Performance

CGEM

140.8%

MGTX

29.4%

Detailed metrics comparison

CGEM

Cullinan Therapeutics Inc

MGTX

MeiraGTx Holdings PLC

Market Cap

CGEM$954M

MGTX$990M

Enterprise Value

CGEM$876M

MGTX$947M

Price

CGEM$15.53

MGTX$10.69

P/E Ratio

CGEMN/A

MGTX12.70x

P/S Ratio

CGEM0.00x

MGTX2.49x

EV/Sales

CGEM0.00x

MGTX2.38x

EV/EBITDA

CGEM8.02x

MGTX4.63x

P/B Ratio

CGEM3.10x

MGTX4.81x

P/FCF Ratio

CGEMN/A

MGTX94.58x

EV/FCF

CGEM-5.50x

MGTX90.47x

PEG Ratio

CGEMN/A

MGTXN/A

Forward P/E (NTM)

CGEMN/A

MGTXN/A

Forward P/S (NTM)

CGEMN/A

MGTX27.71x

Revenue (TTM)

CGEM$0

MGTX$398M

Revenue Growth (YoY)

CGEMN/A

MGTX948.3%

Forward Rev Growth

CGEM244.6%

MGTX-75.7%

Gross Margin (TTM)

CGEM0.0%

MGTX97.9%

Operating Margin (TTM)

CGEM0.0%

MGTX46.3%

EBITDA Margin (TTM)

CGEM0.0%

MGTX49.3%

Net Margin (TTM)

CGEM0.0%

MGTX19.9%

FCF Margin (TTM)

CGEMN/A

MGTX2.6%

Net Income (TTM)

CGEM$-205M

MGTX$79M

FCF (TTM)

CGEM$-159M

MGTX$10M

EPS (TTM)

CGEM-$3.33

MGTX$0.84

ROE (TTM)

CGEM-5289.0%

MGTX74.6%

ROA (TTM)

CGEM-4818.0%

MGTX29.4%

ROIC (TTM)

CGEM-5289.0%

MGTX50.9%

Cash

CGEM$79M

MGTX$143M

Debt

CGEM$0

MGTX$100M

Net Cash/Debt

CGEM$79M

MGTX$43M

Current Ratio (TTM)

CGEM8.42x

MGTX3.76x

Quick Ratio (TTM)

CGEM8.23x

MGTX3.69x

Debt/Equity (TTM)

CGEM0.00x

MGTX0.46x

Debt/Assets (TTM)

CGEM0.0%

MGTX0.0%

Interest Coverage (TTM)

CGEMN/A

MGTXN/A

Net Debt/EBITDA (TTM)

CGEM0.00x

MGTX0.00x

Beta

CGEM-0.03

MGTX1.05

52W Performance

CGEM140.8%

MGTX29.4%

YTD Performance

CGEM53.5%

MGTX36.9%

% from 52W High

CGEM-33.0%

MGTX-30.4%

% from 52W Low

CGEM138.9%

MGTX61.5%

Asset Turnover (TTM)

CGEM0.00x

MGTX1.48x

FCF Yield (TTM)

CGEM-16.7%

MGTX1.1%

Earnings Yield (TTM)

CGEM-21.4%

MGTX8.0%

Dividend Yield (TTM)

CGEMN/A

MGTXN/A

Rule of 40

CGEM0.0

MGTX951.0

EV/GP/RG

CGEMN/A

MGTXN/A

Ticker research

View CGEM research View MGTX research

Metric	CGEM Cullinan Therapeutics Inc	MGTX MeiraGTx Holdings PLC
Market & Valuation
Market Cap	$954M	$990M
Enterprise Value	$876M	$947M
Price	$15.53	$10.69
P/E Ratio	N/A	12.70x
P/S Ratio	0.00x	2.49x
EV/Sales	0.00x	2.38x
EV/EBITDA	8.02x	4.63x
P/B Ratio	3.10x	4.81x
P/FCF Ratio	N/A	94.58x
EV/FCF	-5.50x	90.47x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	27.71x
Revenue & Growth
Revenue (TTM)	$0	$398M
Revenue Growth (YoY)	N/A	948.3%
Forward Rev Growth	244.6%	-75.7%
Profitability
Gross Margin (TTM)	0.0%	97.9%
Operating Margin (TTM)	0.0%	46.3%
EBITDA Margin (TTM)	0.0%	49.3%
Net Margin (TTM)	0.0%	19.9%
FCF Margin (TTM)	N/A	2.6%
Net Income (TTM)	$-205M	$79M
FCF (TTM)	$-159M	$10M
EPS (TTM)	-$3.33	$0.84
ROE (TTM)	-5289.0%	74.6%
ROA (TTM)	-4818.0%	29.4%
ROIC (TTM)	-5289.0%	50.9%
Financial Health
Cash	$79M	$143M
Debt	$0	$100M
Net Cash/Debt	$79M	$43M
Current Ratio (TTM)	8.42x	3.76x
Quick Ratio (TTM)	8.23x	3.69x
Debt/Equity (TTM)	0.00x	0.46x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	-0.03	1.05
52W Performance	140.8%	29.4%
YTD Performance	53.5%	36.9%
% from 52W High	-33.0%	-30.4%
% from 52W Low	138.9%	61.5%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	1.48x
FCF Yield (TTM)	-16.7%	1.1%
Earnings Yield (TTM)	-21.4%	8.0%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	951.0
EV/GP/RG	N/A	N/A
Ticker research	View CGEM research	View MGTX research